Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB35 antisense RNA 1 (RAB35-AS1) is a long non-coding RNA transcribed from the antisense strand of the RAB35 gene. It is annotated in multiple gene databases as a non-protein-coding gene (ENSG00000277283, Gene ID 127138862)[1][2][6]. Its molecular classification is as an antisense long non-coding RNA. There is currently no evidence that RAB35-AS1 is a therapeutic target, nor is it implicated in human disease or as a drug-interacting target. Its functions, interacting partners, and disease roles have not yet been experimentally defined in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB35 antisense RNA 1 (RAB35-AS1).